Developing a Non-Invasive Treatment for Life-Threatening PE – University of Michigan College of Engineering
University of Michigan College of Engineering shared a post on LinkedIn:
“Pulmonary embolism is the third most common cardiovascular killer in the United States after heart attack and stroke. When large blood clots break loose from the legs and travel to the lungs, they block oxygen exchange and put sudden, deadly strain on the heart.
Current emergency options present tough trade-offs: clot-busting drugs can take up to 24 hours to work, fail about a third of the time and carry a serious risk of internal bleeding, while mechanically removing the clot with a catheter device risks tearing fragile blood vessel walls. The most severe clots must be removed through open-chest surgery.
University of Michigan researchers and vascular surgeons are developing a non-invasive treatment with a $3.74M grant from the National Institutes of Health (NIH).”
Stay updated with Hemostasis Today.
-
Oct 19, 2026, 03:28Jim Hoffman: How NETs Contribute to Gallstone Formation and Growth
-
Oct 19, 2026, 03:28Nicolas Hubacz: The Organized Chaos of Mitochondria
-
Oct 19, 2026, 03:02Neda Horvacki: Using ROTEM to Refine Transfusion Decisions in Acute Trauma
-
Oct 19, 2026, 02:45Diego Escarraman Martinez: MATTERs Study – When a Cohort Gave Us Major Clues about TXA in Trauma
-
Oct 19, 2026, 02:35Brian O Mahony: Promoting Physical Activity and Sport in Haemophilia Care
-
Oct 19, 2026, 02:35Malusi Mtetwa: Tranexamic Acid – What Does the Evidence Tell Us?
-
Oct 19, 2026, 02:34Rishabh Mishra: Does the Evidence Support Tranexamic Acid Formulations in Skincare?
-
Oct 18, 2026, 23:31Rana Al-Hrout: MAHA – More Than Schistocytes
-
Oct 18, 2026, 17:11Owen McCarty: Understanding Prekallikrein and Its Role in Inflammation and Thrombosis